Caption Management, LLC Prometheus Biosciences, Inc. Call Options Transaction History

Caption Management, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 15, 2023	SELL	$103.46 - $126.29 $11.9 Million - $14.5 Million	-115,200 Reduced 76.7%	35,000 $3.76 Million
Q4 2022 Feb 14, 2023	BUY	$36.06 - $117.21 $4.91 Million - $16 Million	136,200 Added 972.86%	150,200 $16.5 Million
Q2 2022 Aug 15, 2022	BUY	$22.39 - $38.94 $313,460 - $545,160	14,000 New	14,000 $395,000
Q1 2022 May 13, 2022	SELL	$30.13 - $50.0 $903,900 - $1.5 Million	-30,000 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$22.28 - $39.54 $668,400 - $1.19 Million	30,000 New	30,000 $1.19 Million

29.6K

Ticker RXDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,904,100
Description
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.